Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Inflammatory Bowel Disease (IBD): early-phase trial registry
8 of 13 indexed Inflammatory Bowel Disease (IBD) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,315 of 28,707 conditions by registered trial count.
13 US clinical trials · 8 currently recruiting · #1,315 of 28,707 conditions by registered trial count
Inflammatory Bowel Disease (IBD): 13 US clinical trials tracked, 8 recruiting.
Inflammatory Bowel Disease (IBD) is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Danielle Kim Turgeon, running 1 of these trials.
Enrollment posture brief
Registry condition inflammatory-bowel-disease-ibd
OPEN 8 | RECR 62% | LATE 0 | EARLY 4 | RANK #1315 | SPON 1
Volume-matched condition peers
Nearest open-share peer: High Risk Myelodysplastic Syndrome (62% recruiting · 13 trials)
Inflammatory Bowel Disease (IBD) lists 8 open slots (62% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Inflammatory Bowel Disease (IBD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Inflammatory Bowel Disease (IBD) is recruiting above its size-band peers.
8 of 13 indexed trials (61.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Inflammatory Bowel Disease (IBD) trials is spread across many organizations.
Danielle Kim Turgeon accounts for 1 of 13 trials (7.7%). 13 distinct sponsors appear on at least one study for this condition label.
-
Typical Inflammatory Bowel Disease (IBD) enrolment sits around 120 participants.
Median target enrolment is 120 among the 13 trials that report a genuine target (sentinel values excluded). 5 of those (38.5%) plan for fewer than 100 participants.
-
Inflammatory Bowel Disease (IBD) splits between interventional and observational designs.
6 interventional and 7 observational studies make up this index (46.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
13 total, page 1 of 1
IBD Pregnancy Registry
CorEvitas
NCT06910553
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
Mercy Medical Center
NCT06750731
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
University of North Carolina, Chapel Hill
NCT07237516
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Mirador Therapeutics
NCT07113522
Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD
Connecticut Children's Medical Center
NCT07224113
Evaluation of the SMART IBD App in Pediatric IBD
Children's Hospital Medical Center, Cincinnati
NCT07195123
Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
Massachusetts General Hospital
NCT06655415
Study of DISC-0974-201 in Participants With IBD and Anemia
Disc Medicine
NCT07368972
A Trial of Academic Detailing to Promote Prescribing of Biosimilars
Brigham and Women's Hospital
NCT07221890
Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease
Vanderbilt University Medical Center
NCT07123350
Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine
Boston Children's Hospital
NCT00542776
Study of KCC Peptide Application in the Colon
Danielle Kim Turgeon
NCT02156557
Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases
Corewell Health West
NCT01560819
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Inflammatory Bowel Disease (IBD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Inflammatory Bowel Disease (IBD) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Inflammatory Bowel Disease (IBD) page
13 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 8 Inflammatory Bowel Disease (IBD) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Danielle Kim Turgeon sponsors the most Inflammatory Bowel Disease (IBD) trials on record, review their full trial history before evaluating a specific study. See Danielle Kim Turgeon's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Inflammatory Bowel Disease (IBD) condition card totals 13 registered trials; most-linked intervention Gut Microbial Transplantation; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.